Rhizophora mucronata
What's the taxonomical classification of Rhizophora mucronata?
Rhizophora mucronata belongs to the kingdom Plantae and is classified under the phylum Streptophyta. Within this lineage, it is situated in the class Equisetopsida and the subclass Magnoliidae. The taxonomic hierarchy continues through the order Malpighiales and the family Rhizophoraceae, which leads to its designation within the genus Rhizophora. Ultimately, the specific identity of this plant is defined by its species name, mucronata.
| Taxonomic Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Malpighiales |
| Family | Rhizophoraceae |
| Genus | Rhizophora |
| Species | mucronata |
What are the morphological characteristics of this plant?
Rhizophora mucronata has a woody structure characterized by large, branched stilt roots that emerge from the trunk to provide stability in unstable intertidal mud. The leaves are elliptical to oblong, featuring a leathery texture and a distinct mucronate tip that tapers to a small point. Its bark is typically greyish or brownish and displays a somewhat smooth yet fissured surface as the tree matures. The plant produces long, pendulous flower stalks that bear small, fragrant white flowers with several petals and numerous stamens. Most notably, it develops long, viviparous propagules that germinate while still attached to the parent tree to facilitate rapid colonization.
What is the geographical distribution of this plant?
This plant is distributed across the tropical and subtropical coasts of the Indo-West Pacific region, spanning from the eastern coast of Africa and Madagascar through Southeast Asia to the northern coasts of Australia. It typically inhabits the intertidal zones of muddy estuaries, river mouths, and sheltered bays where salinity levels fluctuate. Within these environments, it establishes dense mangrove forests that serve as critical coastal buffers. Its range is strictly limited by water temperature, as it cannot survive in areas where frost occurs. The species thrives in low-energy coastal settings where fine sediments accumulate to support its complex root systems.
How is this plant cultivated?
This plant is cultivated by planting propagules directly into soft, anaerobic intertidal mud or by nurturing them in nursery beds before transplanting them to coastal restoration sites.
Successful growth requires constant exposure to saltwater tidal cycles and a substrate composed of fine silt or clay. Proper spacing between seedlings is essential to allow for the development of their characteristic stilt roots and to prevent competition for nutrients. Environmental factors such as salinity levels, water temperature, and protection from excessive wave energy must be monitored to ensure survival.
Once established, these mangroves play a vital role in stabilizing shorelines and protecting coastal ecosystems.
What parts of this plant are used medicinally?
This plant Rhizophora mucronaata provides medicinal value through its bark, flowers, fruits, leaves, and roots. The bark is often utilized for its astringent properties to treat various ailments. Extracts from the leaves and flowers are frequently employed in traditional remedies to manage inflammation or skin conditions. The fruits are sometimes processed for their specific nutritional or therapeutic components. Additionally, the roots are used in certain cultures to prepare decoctions for healing.
According to a study published by "Bioscience, biotechnology, and biochemistry", a polysaccharide was extracted with 1% sodium carbonate from the bark of Rhizophora mucronaata. The anti-HIV activity of this alkaline extract was mainly recovered in the 25-75% ethanol-precipitated fraction. This Rhizophora mucronata polysaccharide protected MT-4 cells from HIV-induced cytopathogenicity and blocked the expression of HIV antigens. Furthermore, the polysaccharide completely inhibited viral binding to the cell and the formation of syncytium upon the cocultivation of MOLT-4/HIV-1IIIB cells and MOLT-4 cells. These results suggest that the polysaccharide inhibited early steps of the virus life cycle, especially virus adsorption to the cell.
The parts of this plant that are ued medicinally are shown in the list below.
- bark
- flower
- fruit
- leaf
- root
What traditional systems uses this plant?
This plant, Rhizophora mucronata, has been historically utilized by coastal communities for its tannin-rich bark in the production of high-quality dyes, tanning leather, and treating various ailments.
Indigenous populations often prepared decoctions from the bark to address digestive issues and skin inflammations. The sturdy wood was also traditionally harvested for construction and fuel due to its high density and resistance to decay in saltwater environments. Furthermore, many cultures used the plant's extracts as a medicinal astringent to aid in wound healing.
These diverse applications demonstrate the deep integration of the species into the economic and medicinal practices of mangrove-dependent societies.
What are the pharmacological activities of Rhizophora mucronata?
This plant has demonstrated significant analgesic, anti-inflammatory, antibacterial, antimicrobial, and antioxidant pharmacological activities through its various bioactive secondary metabolites. The presence of polyphenols and tannins within the plant extracts contributes to its ability to neutralize free radicals and reduce oxidative stress. These chemical constituents also effectively inhibit the growth of various pathogenic microorganisms, showcasing potent antimicrobial and antibacterial properties. Furthermore, the extracts help manage pain and swelling by modulating inflammatory pathways in biological systems. These diverse therapeutic actions make Rhizophora mucronata a valuable subject for natural drug development.
According to a study published by "PloS one", Rhizophora mucronaata demonstrates significant antioxidant, antibacterial, analgesic, antidiaabetic, and anticancer properties. In the DPPH free radical scavenging assay, the dichloromethane and ethyl acetate fractions showed IC50 values of 12.18 and 11.7 μg/mL, respectively, compared to 6.36 μg/mL for ascorbic acid. The plant's fractions exhibited antibacterial effects with zones of inhibition measuring between 11.1 and 17.3 mm against Gram-positive bacteria. Regarding cytotoxicity against HeLa cells, the dichloromethane and ethyl acetate fractions had IC50 values of 88.94 µg/ml and 127.6 µg/ml, respectively. Finally, the ethyl acetate fraction provided a maximum cell growth inhibition of 54.61% against Ehrlich ascites carcinoma cells compared to 84.83% inhibition by bleomycin.
The primary pharmacological activities of this plant are shown in the list below.
- analgesic
- anti-inflammaforary
- antibacterial
- anticancer
- antioxidant
What medicinal compounds this plant contains?
This plant contains various bioactive secondary metabolites including tannins, flavonoids, saponins, alkaloids, and terpenoids. The high concentration of polyphenolic compounds like tannins provides the species with significant antioxidant and antimicrobial properties. These chemical constituents allow the plant to defend itself against pathogens while offering potential therapeutic uses for humans. Researchers have specifically investigated its ability to inhibit certain bacteria and reduce oxidative stress in cellular models. Consequently, these medicinal compounds make the species a subject of interest for developing new pharmacological treatments.
What health conditions is this plant used for?
This plant is used for treating cancer, diarrhoea, rotavirus diarrhea, oxidative stress, and type 2 diabetes. The phytochemical properties of Rhizophora mucronata provide potent antioxidant effects that help mitigate cellular oxidative stress. These bioactive compounds also demonstrate significant potential in managing blood glucose levels related to type 2 diabetes. Furthermore, its medicinal extracts are applied to combat gastrointestinal issues such as diarrhoea and rotavirus diarrhea. Research also suggests that its therapeutic constituents may play a role in inhibiting the progression of various types of cancer.
According to a study published by "Bioorganic & medicinal chemistry letters", compounds from the leaves of Rhizophora mucronaata were tested for cytotoxicity against human cancer cell lines HL-60 and HeLa. Compound 16 inhibited the growth of both HeLa cells with an IC50 of 4.8 μM and HL-60 cells with an IC50 of 1.0 μM. Compounds 4, 7, 10, and 12 showed moderate activity against HeLa cells with IC50 values ranging from 3.8 to 8.3 μM. Additionally, compounds 5, 9, 11, and 17 demonstrated moderate activity against HL-60 cells with IC50 values between 2.2 and 6.3 μM. Higher selectivity against HL-60 cell lines was observed for compounds 5, 9, 11, and 16 with SI values of 8.6, 19.2, 9.4, and 10.2, respectively.
The main health conditions this plant is used for are shown in the list below.
- breast cancer
- cancer
- diabehres
- human immunodeficiency virus
- oxidative stress
What are the herbal preparations of this plant?
This plant is used to create medicinal herbal preparations including methanolic leaf extract and ethyl acetate extracts for various therapeutic applications. Researchers utilize these specific solvent extractions to isolate bioactive secondary metabolites like tannins and flavonoids. The methanolic leaf extract is particularly studied for its potent antioxidant and antimicrobial properties. Similarly, ethyl acetate extracts serve to concentrate specific non-polar compounds that may exhibit anti-inflammatory effects. These preparations are fundamental in pharmacological studies aimed at developing new treatments from mangrove resources.
According to a study published by "Pharmaceuctical biology", Rhizophora mucronaata Lam. is used traditionally among Asian countries as folk medicine. For assays, Rhizophora mucronaata leaves were extracted using solvents with dosages of 100-500 µg/ml. The methanolic leaf extract at 500 µg/ml showed the highest inhibitory activity against AChE at 92.73 ± 0.54% and BuChE at 98.98 ± 0.17%, with IC50 values of 59.31 ± 0.35 and 51.72 ± 0.33 µg/ml. This methanolic extract also demonstrated antioxidant IC50 values of 47.39 ± 0.43, 401.45 ± 18.52, 80.23 ± 0.70, and 316.47 ± 3.56 µg/ml for DPPH, hydroxyl, nitric oxide radical, and hydrogen peroxide. Total polyphenolic and flavonoid contents in this extract were 598.13 ± 1.85 µg of gallic acid equivalent and 48.85 ± 0.70 μg of rutin equivalent/mg. The bioactive compound (+)-catechin was identified as being responsible for these activities.
The main herbal preparations of this plant are shown in the list below.
- Methanolic leaf extract
- ethyl acetate extracts
What side effects this plant can have?
This plant can cause hepatotoxicity, neurotoxicity, cell growth inhibition, diabetes, and increased alanine aminotransferase levels in the body. Research indicates that certain extracts from Rhizophora mucronata lead to elevated alanine aminotransferase, which serves as a clinical marker for liver damage. The presence of bioactive compounds in the species may also trigger neurotoxicity by affecting the nervous system. Furthermore, specific components have demonstrated the potential to cause cell growth inhibition during biological processes. These combined toxicological profiles suggest that improper consumption poses significant risks to metabolic and organ health.
According to a study published by "Molecular biology reports", the methanolic leaf extract of Rhizophora mucronata (MERM) showed no mutagenic effect at doses up to 4,000 μg/plate in Salmonella/microsome assay tester strains. In comet assay and cytotoxicity evaluations in PBMC, MERM showed no significant difference in comet tail moment (TM) and tail scores up to 24 h. Acute toxicity studies in Wistar rats using oral single doses of 250-2,000 mg/kg produced no mortality or noticeable behavioral changes, though a significant increase in ALT and AST, hepatotoxicity, and neurotoxicity occurred at the highest dose. Subacute toxicity studies involving the administration of 1,000 mg/kg for 28 consecutive days showed no alteration in body weight gain, behavioral parameters, or hematological and biochemical parameters. Histopathological examination during these 28 days showed normal architecture suggesting no morphological disturbances. Collectively, these data demonstrate that consumption of MERM for various medicinal purpose is safe.
The main side effects this plant can have are shown in the list below.
- hepatotoxicity
- increased alanine aminotransferase
- neurotoxicity
- cell growth inhibition
- diabetes
What herbs are paired with Rhizophora mucronata?
This plant Rhizophora mucronata is frequently paired with herbs such as ginger, turmeric, and lemongrass to enhance its medicinal properties in traditional decoctions.
Combining the bark with ginger helps to mitigate the harshness of its tannins while simultaneously boosting its anti-inflammatory effects. Lemongrass is often added to these mixtures to provide a balancing aromatic quality and to aid in digestive soothing. Turmeric is utilized alongside the rhizophora extract to create a synergistic effect that targets skin infections and wound healing.
These specific herb pairings are carefully selected to optimize the bioavailability of the plant's bioactive compounds.